Scientific Papers and Patents on Substances with Unproven Effects. Part 2

  • Sergei V. Jargin
  • Recent Patents on Drug Delivery & Formulation, January 2020, Bentham Science Publishers
  • DOI: 10.2174/1872211313666190819124752

What is it about?

Several examples are discussed in this review, where substances without proven effects were proposed for the practical use within the scope of the evidence-based medicine. The following is discussed here: generalizations of the hormesis concept and its use in support of homeopathy; phytoestrogens and soy products potentially having feminizing effects; glycosaminoglycans for the treatment of osteoarthritis and possibilities of their replacement by diet modifications; flavonoids recommended for the treatment of chronic venous insufficiency and varicose veins; acetylcysteine as a mucolytic agent and its questionable efficiency especially by an oral intake; stem cells and cell therapies. In conclusion, placebo therapies can be beneficial and ethically justifiable but it is not a sufficient reason to publish biased information. Importantly, placebo must be devoid of adverse effects, otherwise it is named pseudo-placebo. Therapeutic methods with unproven effects should be tested in high quality research shielded from the funding bias. Some issues discussed in this review are not entirely clear, and the arguments provided here can initiate a constructive discussion.

Read Publication

http://dx.doi.org/10.2174/1872211313666190819124752

The following have contributed to this page: Dr Sergei V. Jargin